Which institute received permission to carry out Phase III randomized, Double-blind, Placebo-controlled trial of efficacy, safety, and tolerability of antiviral drugs Umifenovir?

Which institute received permission to carry out Phase III randomized,

1.	Which institute received permission to carry out Phase III randomized, Double-blind, Placebo-controlled trial of efficacy, safety, and tolerability of antiviral drugs Umifenovir?
Answer» CSIR-Central Drug Research Institute Lucknow received permission to carry out Phase III randomized, Double-blind, Placebo-controlled trial of efficacy, safety, and tolerability of antiviral drugs Umifenovir. The Phase III Clinical Trials will be carried out at King George's Medical University (KGMU), Dr. Ram Manohar Lohia Institute of Medical Sciences (RMLIMS), and ERA's Lucknow Medical College & Hospital, Lucknow.